Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 128 articles:
HTML format
Text format



Single Articles


    March 2018
  1. LAUNEY Y, Seguin P
    Is traumatic intracranial haemorrhage a specific risk factor for atrial fibrillation?
    Heart. 2018;104:450.
    PubMed     Text format    


    February 2018
  2. TIKHONOFF V, Kuznetsova T, Thijs L, Cauwenberghs N, et al
    Ambulatory blood pressure and long-term risk for atrial fibrillation.
    Heart. 2018 Feb 9. pii: heartjnl-2017-312488. doi: 10.1136/heartjnl-2017-312488.
    PubMed     Text format     Abstract available


    January 2018
  3. HUANG CY, Yang YH, Lin LY, Tsai CT, et al
    Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312573. doi: 10.1136/heartjnl-2017-312573
    PubMed     Text format     Abstract available


  4. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    PubMed     Text format     Abstract available


  5. AKOUM N
    Persistently high incidence of postcoronary bypass atrial fibrillation: possible mechanisms.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312627. doi: 10.1136/heartjnl-2017-312627
    PubMed     Text format    


  6. VINEREANU D, Wang A, Mulder H, Lopes RD, et al
    Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312272. doi: 10.1136/heartjnl-2017-312272
    PubMed     Text format     Abstract available


  7. FILARDO G, Damiano RJ Jr, Ailawadi G, Thourani VH, et al
    Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312150. doi: 10.1136/heartjnl-2017-312150
    PubMed     Text format     Abstract available


  8. ERWIN JP 3RD, Iung B
    Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony...but not Lockstep!
    Heart. 2018 Jan 11. pii: heartjnl-2017-312758. doi: 10.1136/heartjnl-2017-312758
    PubMed     Text format    


  9. ALONSO A, MacLehose RF, Chen LY, Bengtson LGS, et al
    Oral anticoagulants and liver injury: the threat of uncontrolled confounding.
    Heart. 2018;104:84.
    PubMed     Text format    


    December 2017
  10. OTTO CM
    Heartbeat: Healthcare approaches to reducing adverse outcomes in patients with atrial fibrillation.
    Heart. 2017;103:1925-1927.
    PubMed     Text format    


  11. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Heart. 2017;103:1977-1984.
    PubMed     Text format     Abstract available


    November 2017
  12. BORIANI G, Proietti M
    Atrial fibrillation prevention: an appraisal of current evidence.
    Heart. 2017 Nov 30. pii: heartjnl-2017-311546. doi: 10.1136/heartjnl-2017-311546
    PubMed     Text format     Abstract available


  13. PATTI G
    Patients with atrial fibrillation and coronary events: are we any closer to coming out from the labyrinth of the various antithrombotic strategies?
    Heart. 2017 Nov 25. pii: heartjnl-2017-312576. doi: 10.1136/heartjnl-2017-312576
    PubMed     Text format    


  14. SINDET-PEDERSEN C, Staerk L, Lamberts M, Gerds TA, et al
    Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311976. doi: 10.1136/heartjnl-2017-311976.
    PubMed     Text format     Abstract available


  15. LAZZERINI PE, Laghi-Pasini F, Bertolozzi I, Morozzi G, et al
    Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes.
    Heart. 2017;103:1821-1829.
    PubMed     Text format     Abstract available


    October 2017
  16. WONG JA, Rexrode KM, Sandhu RK, Moorthy MV, et al
    Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation.
    Heart. 2017 Oct 7. pii: heartjnl-2016-311002. doi: 10.1136/heartjnl-2016-311002.
    PubMed     Text format     Abstract available


  17. MARTIN CA, Gajendragadkar PR, Agarwal S
    Palpitations in a 72-year-old woman.
    Heart. 2017;103:1554-1555.
    PubMed     Text format     Abstract available


  18. MARTIN CA, Lambiase PD
    Pathophysiology, diagnosis and treatment of tachycardiomyopathy.
    Heart. 2017;103:1543-1552.
    PubMed     Text format    


    September 2017
  19. PROVIDENCIA R, Karim N, Srinivasan N, Honarbakhsh S, et al
    Impact of QTc formulae in the prevalence of short corrected QT interval and impact on probability and diagnosis of short QT syndrome.
    Heart. 2017 Sep 27. pii: heartjnl-2017-311673. doi: 10.1136/heartjnl-2017-311673
    PubMed     Text format     Abstract available


  20. LIU K, Ahmed J, Feiglin D
    A 54-year-old man with new-onset ventricular fibrillation.
    Heart. 2017 Sep 27. pii: heartjnl-2017-312052. doi: 10.1136/heartjnl-2017-312052
    PubMed     Text format     Abstract available


  21. BAPAT A, Anderson CD, Ellinor PT, Lubitz SA, et al
    Genomic basis of atrial fibrillation.
    Heart. 2017 Sep 11. pii: heartjnl-2016-311027. doi: 10.1136/heartjnl-2016-311027
    PubMed     Text format     Abstract available


  22. TAVERNIER R, Wolf M, Kataria V, Phlips T, et al
    Screening for atrial fibrillation in hospitalised geriatric patients.
    Heart. 2017 Sep 7. pii: heartjnl-2017-311981. doi: 10.1136/heartjnl-2017-311981.
    PubMed     Text format     Abstract available


  23. RAOUF WA, Shams K, Mansour A
    An unusual cause of tachyarrhythmia in an otherwise healthy young man.
    Heart. 2017;103:1472.
    PubMed     Text format     Abstract available


  24. HONARBAKHSH S, Baker V, Kirkby C, Patel K, et al
    Safety and efficacy of paramedic treatment of regular supraventricular tachycardia: a randomised controlled trial.
    Heart. 2017;103:1413-1418.
    PubMed     Text format     Abstract available


  25. ZUMHAGEN S, Vrachimis A, Stegger L, Kies P, et al
    Impact of presynaptic sympathetic imbalance in long-QT syndrome by positron emission tomography.
    Heart. 2017 Sep 1. pii: heartjnl-2017-311667. doi: 10.1136/heartjnl-2017-311667.
    PubMed     Text format     Abstract available


  26. BROUGH C
    Expediting the pathway to supraventricular tachycardia ablation.
    Heart. 2017;103:1471.
    PubMed     Text format    


  27. MCLEOD CJ
    Acute arrhythmias in adults with congenital heart disease.
    Heart. 2017;103:1380-1388.
    PubMed     Text format    


    August 2017
  28. BHAVE PD
    What do our patients think they know about atrial fibrillation? ... Is that asking the right question?
    Heart. 2017 Aug 16. pii: heartjnl-2017-312124. doi: 10.1136/heartjnl-2017-312124
    PubMed     Text format    


  29. KAUFMAN BG, Kim S, Pieper K, Allen LA, et al
    Disease understanding in patients newly diagnosed with atrial fibrillation.
    Heart. 2017 Aug 8. pii: heartjnl-2017-311800. doi: 10.1136/heartjnl-2017-311800.
    PubMed     Text format     Abstract available


  30. GUHL EN, Magnani JW
    Atrial fibrillation and menopause: something else to worry about, or not?
    Heart. 2017 Aug 5. pii: heartjnl-2017-311771. doi: 10.1136/heartjnl-2017-311771.
    PubMed     Text format    


  31. OTTO CM
    Heartbeat: Chocolate and atrial fibrillation.
    Heart. 2017;103:1139-1140.
    PubMed     Text format    


  32. GOUDA P, Veenhuyzen G, Har B
    Fifty-year-old woman with lightheadedness.
    Heart. 2017;103:1224.
    PubMed     Text format    


    July 2017
  33. CHUE CD, Kwok CS, Wong CW, Patwala A, et al
    Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review.
    Heart. 2017 Jul 7. pii: heartjnl-2016-310852. doi: 10.1136/heartjnl-2016-310852.
    PubMed     Text format     Abstract available


  34. STEWART S
    Bringing order to chaos: the case for integrated management of atrial fibrillation.
    Heart. 2017 Jul 6. pii: heartjnl-2017-311519. doi: 10.1136/heartjnl-2017-311519.
    PubMed     Text format    


  35. RYDMAN R, Shiina Y, Diller GP, Niwa K, et al
    Major adverse events and atrial tachycardia in Ebstein's anomaly predicted by cardiovascular magnetic resonance.
    Heart. 2017 Jul 6. pii: heartjnl-2017-311274. doi: 10.1136/heartjnl-2017-311274.
    PubMed     Text format     Abstract available


    June 2017
  36. GHANNAM M, Chugh A
    Indications and appropriate selection of novel oral anticoagulants in patients with atrial fibrillation.
    Heart. 2017 Jun 17. pii: heartjnl-2014-307030. doi: 10.1136/heartjnl-2014-307030
    PubMed     Text format    


  37. ISAEW A, Adderley NJ, Ryan R, Fitzmaurice D, et al
    The treatment of paroxysmal atrial fibrillation in UK primary care.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310927. doi: 10.1136/heartjnl-2016-310927.
    PubMed     Text format     Abstract available


  38. BROENDBERG AK, Nielsen JC, Bjerre J, Pedersen LN, et al
    Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations.
    Heart. 2017;103:901-909.
    PubMed     Text format     Abstract available


  39. LIEW AC, Raphael CE, Mohiaddin R
    A 38-year-old man with progressive dyspnoea and ventricular tachycardia.
    Heart. 2017;103:839.
    PubMed     Text format     Abstract available


  40. PFLAUMER A
    Catecholaminergic polymorphic tachycardia: underestimated and overtreated?
    Heart. 2017;103:889-890.
    PubMed     Text format    


  41. POTPARA TS, Lip GY
    Drug-induced liver injury with oral anticoagulants: a threat or not?
    Heart. 2017;103:809-811.
    PubMed     Text format    


  42. WATSON W, Ring L, Salahshouri P
    84-year-old woman with dizziness.
    Heart. 2017;103:966.
    PubMed     Text format    


  43. HENEGHAN CJ, Spencer EA, Mahtani KR
    Cochrane corner: self-monitoring and self-management of oral anticoagulation.
    Heart. 2017;103:895-896.
    PubMed     Text format    


    May 2017
  44. MOSTOFSKY E, Berg Johansen M, Tjonneland A, Chahal HS, et al
    Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study.
    Heart. 2017 May 23. pii: heartjnl-2016-310357. doi: 10.1136/heartjnl-2016-310357
    PubMed     Text format     Abstract available


  45. POKORNEY SD, Piccini JP
    Chocolate and prevention of atrial fibrillation: what is bad for the pancreas might be good for the atria?
    Heart. 2017 May 23. pii: heartjnl-2016-311026. doi: 10.1136/heartjnl-2016-311026
    PubMed     Text format    


  46. GALLAGHER C, Elliott AD, Wong CX, Rangnekar G, et al
    Integrated care in atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2017 May 10. pii: heartjnl-2016-310952. doi: 10.1136/heartjnl-2016-310952
    PubMed     Text format     Abstract available


  47. BOKMA JP, Winter MM, Vehmeijer JT, Vliegen HW, et al
    QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot.
    Heart. 2017;103:666-671.
    PubMed     Text format     Abstract available


  48. VON ROTZ M, Aeschbacher S, Bossard M, Schoen T, et al
    Risk factors for premature ventricular contractions in young and healthy adults.
    Heart. 2017;103:702-707.
    PubMed     Text format     Abstract available


  49. HENG EL, Gatzoulis MA
    QRS fragmentation in tetralogy of Fallot: clinical utility and risk prediction.
    Heart. 2017;103:645-646.
    PubMed     Text format    


    April 2017
  50. POTPARA TS, Blomstrom-Lundqvist C
    Sex-related differences in atrial fibrillation: can we discern true disparities from biases?
    Heart. 2017 Apr 29. pii: heartjnl-2016-311085. doi: 10.1136/heartjnl-2016-311085
    PubMed     Text format    


  51. MINAMI Y, Hagiwara N
    Enlarged left atrium, atrial fibrillation and adverse outcome in hypertrophic cardiomyopathy: is there a difference between apical and non-apical phenotype?
    Heart. 2017 Apr 28. pii: heartjnl-2017-311501. doi: 10.1136/heartjnl-2017-311501
    PubMed     Text format    


  52. LEE SE, Park JK, Uhm JS, Kim JY, et al
    Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.
    Heart. 2017 Apr 20. pii: heartjnl-2016-310720. doi: 10.1136/heartjnl-2016-310720
    PubMed     Text format     Abstract available


  53. LIN WS, Lin TC, Hung Y, Lin WY, et al
    Traumatic intracranial haemorrhage is in association with an increased risk of subsequent atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2016-310451. doi: 10.1136/heartjnl-2016-310451.
    PubMed     Text format     Abstract available


  54. HENDRIKS JM, Gallagher C, Sanders P
    Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2017-311305. doi: 10.1136/heartjnl-2017-311305.
    PubMed     Text format    


  55. YEO C, Tan VH, Wong KC
    Exercise-induced syncope in a 22-year-old man.
    Heart. 2017;103:642.
    PubMed     Text format     Abstract available


  56. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Text format     Abstract available


    March 2017
  57. ISHIBASHI K, Aiba T, Kamiya C, Miyazaki A, et al
    Arrhythmia risk and beta-blocker therapy in pregnant women with long QT syndrome.
    Heart. 2017 Mar 14. pii: heartjnl-2016-310617. doi: 10.1136/heartjnl-2016-310617
    PubMed     Text format     Abstract available


  58. JACKEVICIUS CA, Tsadok MA, Essebag V, Atzema C, et al
    Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation.
    Heart. 2017 Mar 12. pii: heartjnl-2016-310672. doi: 10.1136/heartjnl-2016-310672
    PubMed     Text format     Abstract available


  59. SEKIGUCHI H, Shimamoto K, Takano M, Kimura M, et al
    Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.
    Heart. 2017 Mar 11. pii: heartjnl-2016-310272. doi: 10.1136/heartjnl-2016-310272
    PubMed     Text format     Abstract available


  60. VOUKALIS C, Lip GY
    Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'.
    Heart. 2017 Mar 3. pii: heartjnl-2017-311162. doi: 10.1136/heartjnl-2017-311162.
    PubMed     Text format    


  61. SVENNBERG E, Henriksson P, Engdahl J, Hijazi Z, et al
    N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
    Heart. 2017 Mar 2. pii: heartjnl-2016-310236. doi: 10.1136/heartjnl-2016-310236.
    PubMed     Text format     Abstract available


  62. BENOIST D, Dubes V, Roubertie F, Gilbert SH, et al
    Proarrhythmic remodelling of the right ventricle in a porcine model of repaired tetralogy of Fallot.
    Heart. 2017;103:347-354.
    PubMed     Text format     Abstract available


  63. HAGNAS MJ, Lakka TA, Kurl S, Rauramaa R, et al
    Cardiorespiratory fitness and exercise-induced ST segment depression in assessing the risk of sudden cardiac death in men.
    Heart. 2017;103:383-389.
    PubMed     Text format     Abstract available


    February 2017
  64. SCHNABEL RB, Pecen L, Ojeda FM, Lucerna M, et al
    Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation.
    Heart. 2017 Feb 22. pii: heartjnl-2016-310406. doi: 10.1136/heartjnl-2016-310406
    PubMed     Text format     Abstract available


  65. LAUW MN, Eikelboom JW, Coppens M, Wallentin L, et al
    Effects of dabigatran according to age in atrial fibrillation.
    Heart. 2017 Feb 17. pii: heartjnl-2016-310358. doi: 10.1136/heartjnl-2016-310358
    PubMed     Text format     Abstract available


    January 2017
  66. OTTO CM
    Heartbeat: Left atrial appendage occlusion for stroke prevention.
    Heart. 2017;103:89-90.
    PubMed     Text format    


  67. KIRCHHOF P
    Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines.
    Heart. 2017 Jan 11. pii: heartjnl-2016-310843. doi: 10.1136/heartjnl-2016-310843
    PubMed     Text format    


  68. BLACK-MAIER E, Piccini JP
    Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
    Heart. 2017 Jan 9. pii: heartjnl-2016-310540. doi: 10.1136/heartjnl-2016-310540.
    PubMed     Text format    


  69. ALONSO A, MacLehose RF, Chen LY, Bengtson LG, et al
    Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.
    Heart. 2017 Jan 5. pii: heartjnl-2016-310586. doi: 10.1136/heartjnl-2016-310586.
    PubMed     Text format     Abstract available


    November 2016
  70. YANG F, Hellyer JA, Than C, Ullal AJ, et al
    Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.
    Heart. 2016 Nov 15. pii: heartjnl-2016-309266. doi: 10.1136/heartjnl-2016-309266
    PubMed     Text format     Abstract available


    October 2016
  71. GUTTMANN OP, Pavlou M, O'Mahony C, Monserrat L, et al
    Predictors of atrial fibrillation in hypertrophic cardiomyopathy.
    Heart. 2016 Oct 28. pii: heartjnl-2016-309672. doi: 10.1136/heartjnl-2016-309672
    PubMed     Text format     Abstract available


  72. BAHIT MC, Lopes RD, Wojdyla DM, Held C, et al
    Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
    Heart. 2016 Oct 24. pii: heartjnl-2016-309901. doi: 10.1136/heartjnl-2016-309901
    PubMed     Text format     Abstract available


  73. BANSAL N, Szpiro A, Masoudi F, Greenlee RT, et al
    Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Heart. 2016 Oct 14. pii: heartjnl-2016-309842. doi: 10.1136/heartjnl-2016-309842
    PubMed     Text format     Abstract available


  74. SVENNBERG E, Engdahl J
    Why should we screen for atrial fibrillation?
    Heart. 2016 Oct 12. pii: heartjnl-2016-310305. doi: 10.1136/heartjnl-2016-310305
    PubMed     Text format    


  75. CHAN NY, Choy CC
    Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram.
    Heart. 2016 Oct 12. pii: heartjnl-2016-309993. doi: 10.1136/heartjnl-2016-309993
    PubMed     Text format     Abstract available


  76. RAHIMI K, Otto CM
    Heartbeat: Is atrial fibrillation ablation effective in patients with hypertrophic cardiomyopathy?
    Heart. 2016;102:1511-2.
    PubMed     Text format    


    September 2016
  77. HEIDBUCHEL H
    The search for the tipping point on when to anticoagulate patients with atrial fibrillation.
    Heart. 2016 Sep 20. pii: heartjnl-2016-310325. doi: 10.1136/heartjnl-2016-310325
    PubMed     Text format    


  78. CAMM AJ, Accetta G, Ambrosio G, Atar D, et al
    Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309832. doi: 10.1136/heartjnl-2016-309832
    PubMed     Text format     Abstract available


  79. SWAANS MJ, Boersma LV
    Atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Heart. 2016 Sep 13. pii: heartjnl-2016-310198. doi: 10.1136/heartjnl-2016-310198
    PubMed     Text format    


  80. MAZUREK M, Lip GY
    To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation.
    Heart. 2016 Sep 12. pii: heartjnl-2016-310255. doi: 10.1136/heartjnl-2016-310255
    PubMed     Text format    


  81. LIND L, Sundstrom J, Stenemo M, Hagstrom E, et al
    Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
    Heart. 2016 Sep 8. pii: heartjnl-2016-309764. doi: 10.1136/heartjnl-2016-309764.
    PubMed     Text format     Abstract available


  82. SAHAY S, Nombela-Franco L, Rodes-Cabau J, Jimenez-Quevedo P, et al
    Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Heart. 2016 Sep 1. pii: heartjnl-2016-309782. doi: 10.1136/heartjnl-2016-309782.
    PubMed     Text format     Abstract available


    August 2016
  83. ALLAN V, Banerjee A, Shah AD, Patel R, et al
    Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.
    Heart. 2016 Aug 31. pii: heartjnl-2016-309910. doi: 10.1136/heartjnl-2016-309910
    PubMed     Text format     Abstract available


  84. NIELSEN JC, Johannessen A, Raatikainen P, Hindricks G, et al
    Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
    Heart. 2016 Aug 26. pii: heartjnl-2016-309781. doi: 10.1136/heartjnl-2016-309781
    PubMed     Text format     Abstract available


  85. AKOUM N
    New perspectives on atrial fibrillation and stroke.
    Heart. 2016 Aug 24. pii: heartjnl-2015-309066. doi: 10.1136/heartjnl-2015-309066
    PubMed     Text format     Abstract available


  86. AYABE K, Goto S
    Comparative registries of atrial fibrillation from Japan and the UK: is there a difference between the east and west ends of the Eurasian continent?
    Heart. 2016 Aug 12. pii: heartjnl-2016-310024. doi: 10.1136/heartjnl-2016-310024
    PubMed     Text format    


  87. BUI AH, Roujol S, Foppa M, Kissinger KV, et al
    Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
    Heart. 2016 Aug 11. pii: heartjnl-2016-309303. doi: 10.1136/heartjnl-2016-309303
    PubMed     Text format     Abstract available


  88. CUYPERS JA, Menting ME, Opic P, Utens EM, et al
    The unnatural history of pulmonary stenosis up to 40 years after surgical repair.
    Heart. 2016 Aug 11. pii: heartjnl-2015-309159. doi: 10.1136/heartjnl-2015-309159
    PubMed     Text format     Abstract available


  89. BERTI S, Pastormerlo LE, Rezzaghi M, Trianni G, et al
    Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
    Heart. 2016 Aug 4. pii: heartjnl-2015-309150. doi: 10.1136/heartjnl-2015-309150.
    PubMed     Text format     Abstract available


    June 2016
  90. PRUTKIN JM, Owens DS
    Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Heart. 2016 Jun 22. pii: heartjnl-2016-309761. doi: 10.1136/heartjnl-2016-309761
    PubMed     Text format    


  91. SENOO K, An Y, Ogawa H, Lane DA, et al
    Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom.
    Heart. 2016 Jun 16. pii: heartjnl-2016-309741. doi: 10.1136/heartjnl-2016-309741
    PubMed     Text format     Abstract available


  92. LILLO-CASTELLANO JM, Marina-Breysse M, Gomez-Gallanti A, Martinez-Ferrer JB, et al
    Safety threshold of R-wave amplitudes in patients with implantable cardioverter defibrillator.
    Heart. 2016 Jun 13. pii: heartjnl-2016-309295. doi: 10.1136/heartjnl-2016-309295
    PubMed     Text format     Abstract available


  93. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Text format     Abstract available


  94. KHAIRY P
    Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Heart. 2016 Jun 1. pii: heartjnl-2015-309069. doi: 10.1136/heartjnl-2015-309069.
    PubMed     Text format     Abstract available


  95. GUNGOR B
    Obesity and atrial fibrillation: can adipokines help to solve this puzzle.
    Heart. 2016 Jun 1. pii: heartjnl-2016-309751. doi: 10.1136/heartjnl-2016-309751.
    PubMed     Text format    


    May 2016
  96. PROVIDENCIA R, Elliott P, Patel K, McCready J, et al
    Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Heart. 2016 May 27. pii: heartjnl-2016-309406. doi: 10.1136/heartjnl-2016-309406
    PubMed     Text format     Abstract available


  97. ERMAKOV S, Azarbal F, Stefanick ML, LaMonte MJ, et al
    The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.
    Heart. 2016 May 4. pii: heartjnl-2015-308927. doi: 10.1136/heartjnl-2015-308927.
    PubMed     Text format     Abstract available


  98. OTTO CM
    Heartbeat: Detection of arrhythmias in older adults with falls and syncope.
    Heart. 2016;102:651-2.
    PubMed     Text format    


  99. GROSSMAN SA
    Dysrhythmia and occult syncope as an explanation for falls in older patients.
    Heart. 2016;102:657.
    PubMed     Text format    


  100. KWOK CS, Rashid M, Beynon R, Barker D, et al
    Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis.
    Heart. 2016;102:672-80.
    PubMed     Text format     Abstract available


  101. BHANGU J, McMahon CG, Hall P, Bennett K, et al
    Long-term cardiac monitoring in older adults with unexplained falls and syncope.
    Heart. 2016;102:681-6.
    PubMed     Text format     Abstract available


    April 2016
  102. OTTO CM
    Heartbeat: Inflammatory biomarkers in atrial fibrillation.
    Heart. 2016;102:485-6.
    PubMed     Text format    


  103. DE MATTIA L, Calzolari V, Crosato M
    The implantable defibrillator that predicted the future.
    Heart. 2016;102:e2.
    PubMed     Text format    


    March 2016
  104. KAUFMANN PA, Stehli J
    Non-invasive imaging for prediction of ventricular arrhythmias.
    Heart. 2016 Mar 22. pii: heartjnl-2015-309238. doi: 10.1136/heartjnl-2015-309238
    PubMed     Text format    


  105. ARO AL
    First-degree atrioventricular block: risk marker or innocent finding?
    Heart. 2016 Mar 2. pii: heartjnl-2015-309256. doi: 10.1136/heartjnl-2015-309256.
    PubMed     Text format    


  106. KIM HJ, Kim JB, Jung SH, Choo SJ, et al
    Surgical ablation of atrial fibrillation in patients with a giant left atrium undergoing mitral valve surgery.
    Heart. 2016 Mar 2. pii: heartjnl-2015-308482. doi: 10.1136/heartjnl-2015-308482.
    PubMed     Text format     Abstract available


  107. SIEIRA J, Conte G, Ciconte G, de Asmundis C, et al
    Clinical characterisation and long-term prognosis of women with Brugada syndrome.
    Heart. 2016;102:452-8.
    PubMed     Text format     Abstract available


    February 2016
  108. BATRA G, Svennblad B, Held C, Jernberg T, et al
    All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
    Heart. 2016 Feb 29. pii: heartjnl-2015-308678. doi: 10.1136/heartjnl-2015-308678
    PubMed     Text format     Abstract available


  109. BREITHARDT G, Baumgartner H, Berkowitz SD, Hellkamp AS, et al
    Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.
    Heart. 2016 Feb 17. pii: heartjnl-2015-308120. doi: 10.1136/heartjnl-2015-308120
    PubMed     Text format     Abstract available


  110. OKUMURA Y
    Inflammatory biomarkers in atrial fibrillation: are they linked to future outcomes?
    Heart. 2016 Feb 10. pii: heartjnl-2015-309079. doi: 10.1136/heartjnl-2015-309079
    PubMed     Text format    


  111. VILLABLANCA PA, Rao G, Briceno DF, Lombardo M, et al
    Therapeutic hypothermia in ST elevation myocardial infarction: a systematic review and meta-analysis of randomised control trials.
    Heart. 2016 Feb 10. pii: heartjnl-2015-308559. doi: 10.1136/heartjnl-2015-308559
    PubMed     Text format     Abstract available


  112. RIJNIERSE MT, Allaart CP, de Haan S, Harms HJ, et al
    Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction.
    Heart. 2016 Feb 3. pii: heartjnl-2015-308467. doi: 10.1136/heartjnl-2015-308467.
    PubMed     Text format     Abstract available


  113. HIJAZI Z, Aulin J, Andersson U, Alexander JH, et al
    Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
    Heart. 2016 Feb 2. pii: heartjnl-2015-308887. doi: 10.1136/heartjnl-2015-308887.
    PubMed     Text format     Abstract available


  114. KIZER JR
    Adiponectin and atrial fibrillation in older adults.
    Heart. 2016;102:254.
    PubMed     Text format    


  115. KAWADA T
    Total and high-molecular-weight adiponectin are associated with incident atrial fibrillation.
    Heart. 2016;102:254.
    PubMed     Text format    


  116. ORWAT S, Diller GP, Kempny A, Radke R, et al
    Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot.
    Heart. 2016;102:209-15.
    PubMed     Text format     Abstract available


  117. KUSANO KF, Satomi K
    Diagnosis and treatment of cardiac sarcoidosis.
    Heart. 2016;102:184-90.
    PubMed     Text format     Abstract available


    January 2016
  118. JAWAD-UL-QAMAR M, Kirchhof P
    Almanac 2015: atrial fibrillation research in Heart.
    Heart. 2016 Jan 20. pii: heartjnl-2015-307809. doi: 10.1136/heartjnl-2015-307809
    PubMed     Text format     Abstract available


  119. PRUTKIN JM, Ackerman MJ, Drezner JA
    Athletes with implantable cardioverter defibrillators: can they return to competitive sports?
    Heart. 2016;102:93-4.
    PubMed     Text format    


  120. VALEUR N, Merie C, Hansen ML, Torp-Pedersen C, et al
    Risk of death and stroke associated with anticoagulation therapy after mitral valve repair.
    Heart. 2016 Jan 4. pii: heartjnl-2015-308272. doi: 10.1136/heartjnl-2015-308272.
    PubMed     Text format     Abstract available


  121. AUFFRET V, Loirat A, Leurent G, Martins RP, et al
    High-degree atrioventricular block complicating ST segment elevation myocardial infarction in the contemporary era.
    Heart. 2016;102:40-9.
    PubMed     Text format     Abstract available


  122. WILLCOX ME, Kudenchuk PJ, Prutkin JM
    Very abnormal T waves in a 37-year-old man.
    Heart. 2016;102:163-4.
    PubMed     Text format    


    December 2015
  123. HODES AR, Tichnell C, Te Riele AS, Murray B, et al
    Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308624. doi: 10.1136/heartjnl-2015-308624
    PubMed     Text format     Abstract available


  124. CHIRILLO F, Fusaro M, Morana G, Olivari Z, et al
    An intriguing intracardiac mass in a woman with atrial fibrillation.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308704. doi: 10.1136/heartjnl-2015-308704
    PubMed     Text format    


    November 2015
  125. MAHTANI KR, Nunan D, Heneghan C
    Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
    Heart. 2015;101:1689-90.
    PubMed     Text format    


    October 2015
  126. KUMAR V, Eltelbany M, Fonbah W
    Palpitations in a 46-year-old man.
    Heart. 2015;101:1561.
    PubMed     Text format    


  127. OTTO CM
    Heartbeat: highlights from this issue.
    Heart. 2015;101:1603-4.
    PubMed     Text format    


    August 2015
  128. DIZON JM, Nazif TM, Hess PL, Biviano A, et al
    Chronic pacing and adverse outcomes after transcatheter aortic valve implantation.
    Heart. 2015 Aug 10. pii: heartjnl-2015-307666. doi: 10.1136/heartjnl-2015-307666
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: